![Tracy Saxton](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tracy Saxton
Vorstandsvorsitzender bei
Aucupo Biosciences, Inc.
Profil
Tracy Saxton is the founder of Aucupo Biosciences, Inc. She is currently a Fellow at The Damon Runyon Cancer Research Foundation.
Previously, she held positions as a Director at Millendo Therapeutics US, Inc., PanOptica, Inc., and MISSION Therapeutics Ltd. She was also a Principal at Amgen, Inc., Geron Corp., Tularik, Inc., Threshold Pharmaceuticals, Inc., Cyterix Pharmaceuticals, Inc., and Rempex Pharmaceuticals, Inc. Additionally, she served as an Investment Director at Roche Ventures from 2015 to 2017 and as a Managing Director at Dolby Family Ventures LLC from 2020 to 2022.
She was a Director at Vaxcyte, Inc., Entasis Therapeutics, Inc., and Lengo Therapeutics, Inc. from 2017 to 2017, 2019 to 2021, and 2017 to 2017, respectively.
She also worked as a Managing Partner at Pivotal Bioventure Partners Investment Advisor LLC in 2017.
Dr. Saxton holds an MBA from The Trustees of Columbia University in The City of New York, an undergraduate degree from Simon Fraser University, and a doctorate from the University of Toronto.
Aktive Positionen von Tracy Saxton
| Unternehmen | Position | Beginn |
|---|---|---|
The Damon Runyon Cancer Research Foundation
 The Damon Runyon Cancer Research Foundation Miscellaneous Commercial ServicesCommercial Services Supports cancer research | Corporate Officer/Principal | - |
Aucupo Biosciences, Inc.
 Aucupo Biosciences, Inc. BiotechnologyHealth Technology Engages in research and development of therapeutics | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Tracy Saxton
| Unternehmen | Position | Ende |
|---|---|---|
Dolby Family Ventures LLC
 Dolby Family Ventures LLC Investment ManagersFinance Dolby Family Ventures invests in companies located across the globe primarily in the United States. The firm focuses on life sciences and technology sectors such as precision neuroscience, life sciences platforms, climate, digital and aerospace. It participates in pre-seed, seed, early and later stage transactions. The firm also makes follow-on investments. | Private Equity Investor | 30.06.2022 |
Lengo Therapeutics, Inc.
 Lengo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops small molecule precision therapeutics that target driver mutations in oncology | Vorstandsvorsitzender | - |
Pivotal Bioventure Partners Investment Advisor LLC
 Pivotal Bioventure Partners Investment Advisor LLC Investment ManagersFinance Pivotal Bioventure invests in companies located in the United States and Europe. The firm focuses on biotechnology and innovative therapeutic products. It participates in seed, early and later stage capital transactions. | Private Equity Investor | 31.12.2017 |
Entasis Therapeutics, Inc.
 Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for infectious diseases | Direktor/Vorstandsmitglied | 01.12.2017 |
Roche Ventures
 Roche Ventures Investment ManagersFinance Roche Ventures invests in companies located in Switzerland and the United States. The firm focuses on pharmaceuticals, diagnostics and digital health. It participates in early stage capital transactions with an investment size of CHF 3 - 10 million. It acquires minority stakes and also makes follow-on financing. | Private Equity Investor | 31.01.2017 |
Ausbildung von Tracy Saxton
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
54
Beziehungen ersten Grades
20
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 20 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Geron Corp.
 Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in cancer and inflammatory disease treatments | Commercial Services |
Threshold Pharmaceuticals, Inc.
 Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Cyterix Pharmaceuticals, Inc.
 Cyterix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Developes cancer therapeutics | Health Technology |
Millendo Therapeutics US, Inc.
 Millendo Therapeutics US, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company which develops a novel treatment for adrenal cancer | Health Technology |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Simon Fraser University
 Simon Fraser University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Damon Runyon Cancer Research Foundation
The Damon Runyon Cancer Research Foundation Miscellaneous Commercial ServicesCommercial Services Supports cancer research | Commercial Services |
Roche Ventures
Roche Ventures Investment ManagersFinance Roche Ventures invests in companies located in Switzerland and the United States. The firm focuses on pharmaceuticals, diagnostics and digital health. It participates in early stage capital transactions with an investment size of CHF 3 - 10 million. It acquires minority stakes and also makes follow-on financing. | Finance |
PanOptica, Inc.
 PanOptica, Inc. Pharmaceuticals: MajorHealth Technology Manufactures ophthalmology drugs for treatment of eye diseases | Health Technology |
MISSION Therapeutics Ltd.
 MISSION Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs targeting enzymes involved in cancer and other diseases | Health Technology |
Rempex Pharmaceuticals, Inc.
 Rempex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers new antibacterial drugs | Health Technology |
Dolby Family Ventures LLC
Dolby Family Ventures LLC Investment ManagersFinance Dolby Family Ventures invests in companies located across the globe primarily in the United States. The firm focuses on life sciences and technology sectors such as precision neuroscience, life sciences platforms, climate, digital and aerospace. It participates in pre-seed, seed, early and later stage transactions. The firm also makes follow-on investments. | Finance |
Vaxcyte, Inc.
 Vaxcyte, Inc. BiotechnologyHealth Technology Develops vaccines for infectious diseases | Health Technology |
Entasis Therapeutics, Inc.
Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for infectious diseases | Health Technology |
Pivotal Bioventure Partners Investment Advisor LLC
Pivotal Bioventure Partners Investment Advisor LLC Investment ManagersFinance Pivotal Bioventure invests in companies located in the United States and Europe. The firm focuses on biotechnology and innovative therapeutic products. It participates in seed, early and later stage capital transactions. | Finance |
Aucupo Biosciences, Inc.
Aucupo Biosciences, Inc. BiotechnologyHealth Technology Engages in research and development of therapeutics | Health Technology |
Lengo Therapeutics, Inc.
Lengo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops small molecule precision therapeutics that target driver mutations in oncology | Health Technology |
